CNO Financial Group, Inc. (NYSE:CNO)
CNO Financial Group, Inc. is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer supplemental health insurance, annuity, individual life insurance and other insurance products. The Company serves Americaâ€™s middle-income consumers, with a focus on seniors. It manages its business through the following three primary operating segments: Bankers Life, Colonial Penn and Conseco Insurance Group. Bankers Life markets and distributes health and life insurance products and annuities to the middle-income senior market. Colonial Penn markets primarily graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, the internet and telemarketing. Conseco Insurance Group markets and distributes specified disease insurance, accident, disability, life insurance and annuities to middle-income consumers at home and at the worksite. CNO Financial Group, Inc. is headquartered in Carmel, Indiana.
CNO Financial Group, Inc. (NYSE:CNO)â€™s Financial Overview
CNO Financial Group, Inc. (NYSE) surged 0.55% yesterday to close its trading session at $16.5. The company has 1 year Price Target of $23.17. CNO Financial Group, Inc. has 52-Week high of $26.47 and 52-Week Low of $13.64. The stock touched its 52-Week High on 26.47 and 52-Week Low on 13.64. The stock traded with the volume of 985969 shares yesterday. The firm shows the market capitalization of $2.72 Billion.
CNO Financial Group, Inc. (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.53/share against the analyst consensus estimate of $0.51/share. The difference between the actual and expected EPS is $0.02 a share with a surprise factor of 3.9%.
The firm is trading with SMA20 of 7.7 Percent, SMA50 of -3.57 Percent and SMA200 of -17 percent. CNO Financial Group, Inc. has P/S value of 0.59 while its P/B value stands at 0.75. Similarly, the company has Return on Assets of -1.3 percent, Return on Equity of -9.4 percent and Return on Investment of 5.3 Percent. The company shows Gross Margin and Operating Margin of 0 percent and -0.8 percent respectively.
The Stock currently has Analystâ€™ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 6 analysts offering 12-month price forecasts for CNO Financial Group Inc have a median target of 23.00, with a high estimate of 29.00 and a low estimate of 17.00. The median estimate represents a +39.39% increase from the last price of 16.50.
CNO Financial Group, Inc. is estimated to report earnings on 02/12/2019. The upcoming earnings date is derived from an algorithm based on a companyâ€™s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analystsâ€™ forecasts, the consensus EPS forecast for the quarter is $0.53. The reported EPS for the same quarter last year was $0.61.
McCormick & Company, Incorporated (NYSE:MKC)
McCormick & Company, Inc. is initiating a recall of products manufactured with HVP (hydrolyzed vegetable protein) supplied by Basic Food Flavors of Las Vegas, Nevada, because the ingredient has the potential to be contaminated with Salmonella. Consumption of products containing Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody) and nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms) endocarditis and arthritis.
McCormick & Company, Incorporated (NYSE:MKC)â€™s Financial Outlook
The 12 analysts offering 12-month price forecasts for McCormick & Company Inc have a median target of 127.00, with a high estimate of 150.00 and a low estimate of 107.00. The median estimate represents a -9.85% decrease from the last price of 140.88.
McCormick & Company, Incorporated is expected* to report earnings on 01/24/2019 before market open. The report will be for the fiscal Quarter ending Nov 2018. According to Zacks Investment Research, based on 4 analystsâ€™ forecasts, the consensus EPS forecast for the quarter is $1.69. The reported EPS for the same quarter last year was $1.54.
According to Zacks Investment Research, McCormick & Company, Incorporated has a Consensus Recommendation of 3. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 0.42% and closed its last trading session at $140.88. The company has the market capitalization of $18.41 Billion. The stock has 52-week high of $156 and 52-Week low of $98.34. The firm touched its 52-Week high on 156.00 and 52-Week low on 98.34. The company has volume of 1.21 Million shares. The company has a total of 130.68 Million shares outstanding.
McCormick & Company, Incorporated (NYSE) in the last quarter reported its actual EPS of $1.28/share where the analyst estimated EPS was $1.27/share. The difference between the actual and Estimated EPS is $0.01. This shows a surprise factor of 0.8 percent.
The company has YTD performance of 1.18 percent. Beta for McCormick & Company, Incorporated stands at 0.41 while its ATR (average true range) is 3.48. The company has Weekly Volatility of 2.07%% and Monthly Volatility of 2.69%%.
McCormick & Company, Incorporated has distance from 20-day Simple Moving Average (SMA20) of -0.92%, Distance from 50-Day Simple Moving Average of -3.13 percent and Distance from 200-Day Simple Moving Average of 13.68%.
The Company currently has ROA (Return on Assets) of 8.6 percent, Return on Equity (ROE) of 30.5 Percent and Return on Investment (ROI) of 7.3% with Gross margin of 43.7 percent and Operating & Profit margin of 16.2% and 16.6% respectively.